Overexpression of MYEOV has been associated with poor prognosis in different cancers (Janssen et al., 2002a; Janssen et al., 2002b; Leyden et al., 2006; Moss et al., 2006; Moreaux et al., 2010; Takita et al., 2011; Fang et al., 2019; Liang et al., 2020; Shen et al., 2021). Here, MYEOV is linked to cancer.